CIK 0000921299 · Non-accelerated filer<br>Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770357827
- Phone
- 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Singer Andrew E. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2026-09-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −22 | $8.55 | $188 | 4,355 |
| 2026-09-06 | Wettig Thane CEO | Shares withheld for taxes | −209 | $8.55 | $2K | 26,796 |
| 2026-06-12 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2026-06-12 | Schoeneck James A Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2026-06-12 | Kauffman Michael Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2026-06-12 | EDWARDS JEFFREY L Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2026-06-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −52 | $6.71 | $349 | 4,377 |
| 2026-06-06 | Wettig Thane CEO | Shares withheld for taxes | −198 | $6.71 | $1K | 27,005 |
| 2026-05-14 | Wettig Thane CEO | Purchase | +2,800 | $7.09 | $20K | 27,203 |
| 2026-05-14 | Wettig Thane CEO | Purchase | −2,800 | $7.09 | $20K | 27,203 |
| 2026-03-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −60 | $6.84 | $410 | 4,429 |
| 2026-03-06 | Wettig Thane CEO | Shares withheld for taxes | −277 | $6.84 | $2K | 24,403 |
| 2026-02-03 | DeLucia David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2026-02-03 | Wettig Thane CEO | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2025-12-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −52 | $8.42 | $438 | 4,489 |
| 2025-12-06 | Wettig Thane CEO | Shares withheld for taxes | −259 | $8.42 | $2K | 24,680 |
| 2025-11-17 | Wettig Thane CEO | Purchase | +2,700 | $9.10 | $25K | 24,939 |
| 2025-11-13 | Wettig Thane CEO | Purchase | +1,000 | $9.18 | $9K | 22,239 |
| 2025-09-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −53 | $12.10 | $641 | 4,541 |
Page 1 of 8 · 156 trades